Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4090)
All Articles published online
|
Publishing Process of This Article
|
Jan 16, 2023 (publication date) through Jul 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ou GC, Luo W, Zhang WS, Wang SH, Zhao J, Zhao HM, Qiu R. Gefitinib improves severe bronchorrhea and prolongs the survival of a patient with lung invasive mucinous adenocarcinoma: A case report. World J Clin Cases 2023; 11(2): 441-448 [PMID: 36686363 DOI: 10.12998/wjcc.v11.i2.441] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i2/441.htm |
| Number | Citing Articles |
| 1 |
Pedireddi Sobitha Rani, Singireddy Anand Reddy, Kususma Anusha, Pola Kranthi Kumar, Pulla Udaya Chanrika. An Overview on Tyrosine Kinase Inhibitor Gefitinib Drug Delivery Systems for Enhanced Treatment of Cancer. Biosciences Biotechnology Research Asia 2025; 22(1): 223 doi: 10.13005/bbra/3356
|
| 2 |
Ya-Nan Zhang, Kexin Cao, Yu Yang, Tong Wei, Meng-Jie Li, Jin-Xia Wei, Qiu-Lian Liu. Case Report: Do not diagnose lung cancer as pneumonia: continue to monitor a case of invasive mucinous adenocarcinoma as it progresses from small to large. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1578874
|